To further investigate whether GFAT1 expression could stratify patients by different TNM stages, we divided the HCC patients into early-stage (TNM I–II) and advanced-stage (TNM III–IV) groups. The gene discussed is GFPT1; the disease is hepatocellular carcinoma.